ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO1084

Flu Vaccination Rates in Adults with Kidney Diseases Across Flu Seasons: Effect of Mailed Fliers

Session Information

Category: CKD (Non-Dialysis)

  • 2301 CKD (Non-Dialysis): Epidemiology, Risk Factors, and Prevention

Authors

  • Toth-Manikowski, Stephanie M., Healthmap Solutions, Tampa, Florida, United States
  • Shaps, Howard, Healthmap Solutions, Tampa, Florida, United States
  • Forte, Abigail, Healthmap Solutions, Tampa, Florida, United States
Background

Influenza (flu) vaccination lowers infection and flu-related complications in chronic kidney disease (CKD) and end-stage kidney disease (ESKD). In general populations, mailed flu fliers increase vaccine uptake. Healthmap Solutions, a kidney population health management company, mailed fliers to adults with CKD/ESKD to see how this impacted vaccination rates compared to controls.

Methods

Using payor claims, we identified adults with Stage 3-5 CKD/ESKD who weren't vaccinated against flu in the 2023-24 flu season and mailed them an educational flier prior to the 2024-25 flu season. We matched controls based on variables identified via LASSO selection: insurance type, age group, race/ethnicity, and rurality. The matching process used the nearest neighbor method (match ratio=1; caliper=0.2). A difference-in-differences (DID) analysis compared vaccine rates between the 2022-23 and 2024-25 flu seasons; the 2023-24 flu season was not used as a pre-treatment outcome for the DID analysis as it was used as part of the inclusion criteria.

Results

We matched 6,626 individuals. Covariate balance was strong; mean absolute standardized difference was 0.03 with no significant imbalances across variables (Table). Both groups had increased vaccination rates between flu seasons (intervention: 11.4% to 16.6%; controls: 17.0% to 21.7%), representing a relative increase of 9.0% over the control group's improvement. However, the effect of the flier campaign was minimal and not significant (absolute difference 0.4%, 95% CI: -1.4% to 2.2%, p=0.6).

Conclusion

Mailing fliers to CKD/ESKD adults previously been unvaccinated against flu was associated with a directionally positive impact which may have ultimately been attributed to chance rather than a true impact of the flier campaign. More studies are needed to identify strategies to boost vaccine uptake in this high-risk group.

Digital Object Identifier (DOI)